Smith Stan bought MAIA

June 1, 2026 · Form 4 insider transaction

Smith Stan bought 75,000 shares of MAIA Biotechnology, Inc. at $1.34 per share, a transaction worth $100.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
75,000
Price
$1.34
Total value
$100.2K
InsiderSmith Stan
Role
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 1, 2026
Filing dateJune 2, 2026
Shares owned after1,519,178
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.32 to $1.40, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.; These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

View the original Form 4 on SEC EDGAR